Namandje Bumpus - Director at Recursion Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Namandje Bumpus since 10/7/2024

Holdings reported by Namandje Bumpus for Recursion Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 47.6K $214K $4.51 Jun 18, 2025 Direct
Stock Option (Right to Buy) 22K Jun 18, 2025 Direct Class A Common Stock

Transactions reported by Namandje Bumpus for Recursion Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.